Across TCGA patient cohorts, CHRM5 RNA expression is significantly associated with the go_rna of many other GO terms, with 7,068 significant associations in total. STAD shows the largest number of these associations.

The most reproducible CHRM5-associated GO terms across cancer lineages are Peptidyl-lysine acetylation, Regulation of DNA-templated transcription elongation, and RNA capping. Each is linked with CHRM5 in more than 28 cancer types. Because this analysis shows association rather than direction, both CHRM5-to-partner and partner-to-CHRM5 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (CHRM5→partner) and Y-score (partner→CHRM5) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
STAD	Peptidyl-lysine acetylation →	+0.074	+0.207	<.001	<.001	3	29
STAD	Regulation of DNA-templated transcription elongation →	+0.081	+0.272	<.001	<.001	3	29
STAD	RNA capping →	+0.070	+0.227	<.001	<.001	3	29
STAD	Peptidyl-lysine modification →	+0.072	+0.275	<.001	<.001	3	28
STAD	Protein-containing complex disassembly →	+0.073	+0.254	<.001	<.001	3	28
STAD	TORC1 signaling →	+0.083	+0.230	<.001	<.001	3	28

Each partner links to its Q-omics profile. Showing the 6 strongest of 7,068 associations by consensus.

Exploration

CHRM5 survival (RNA) · tumor vs normal (RNA) · all CHRM5 data types